CANTARGIA
The company is based on the original discovery that leukemic stem cells in patients with chronic myeloid leukemia (CML) express a cell-surface receptor, whereas corresponding normal hematopoietic stem cells do not express this receptor. Stem cells from patients with acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL) has also been shown to have and upregulation of the receptor. Cantargia uses this receptor, the Interleukin-1 receptor accessory protein (IL1RAP), as the target for development of a novel antibody-based therapy for leukemia
CANTARGIA
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2010-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.cantargia.com
Total Employee:
1+
Status:
Active
Contact:
46 4 62 75 62 60
Email Addresses:
[email protected]
Total Funding:
25.73 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Font Awesome Apache Microsoft Exchange Online
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
LUBio Science
LUBio Science investment in Venture Round - Cantargia
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Venture Round - Cantargia
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-08 | Cantargia appoints Dr. Dominique Tersago as Chief Medical Officer |
| 2020-06-23 | Cantargia strengthens management team with VP Regulatory Affairs and VP CMC |
| 2020-02-25 | Cantargia appoints Dr. Ignacio Garcia-Ribas as Chief Medical Officer |
Official Site Inspections
http://www.cantargia.com Semrush global rank: 6.61 M Semrush visits lastest month: 931
- Host name: srv08.style4.se
- IP address: 46.246.39.203
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
